Equities

Curvebeam AI Ltd

Curvebeam AI Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.105
  • Today's Change-0.015 / -12.50%
  • Shares traded140.59k
  • 1 Year change-72.15%
  • Beta--
Data delayed at least 20 minutes, as of Nov 18 2024 01:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Monday, Curvebeam AI Ltd (CVB:ASX) closed at 0.105, 16.67% above the 52 week low of 0.09 set on Nov 01, 2024.
52-week range
Today
0.09Nov 01 20240.4011Dec 29 2023
Open0.12
High0.12
Low0.105
Bid0.10
Offer0.115
Previous close0.12
Average volume306.59k
Shares outstanding317.60m
Free float133.84m
P/E (TTM)--
Market cap38.11m AUD
EPS (TTM)-0.0774
AUD
Data delayed at least 20 minutes, as of Nov 18 2024 01:10 GMT.
More ▼

Events & Activity

  • CVB:ASX price moved over -8.33% to 0.11
  • CVB:ASX trading volume exceeds daily average by +38.08%
  • CVB:ASX price falls below 15-day moving average to 0.105 at 20:10 GMT
  • CVB:ASX price rises above 15-day moving average to 0.12 at 23:28 GMT
  • CVB:ASX price falls below 15-day moving average to 0.11 at 23:49 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.